Bruce Keyt, Chief Scientific Officer at IGM Biosciences, Inc. (IGMS), sold 25,000 shares at $22.84 ($571K) on 2022-10-04, disclosed to the SEC on 2022-10-06.
Open-market sale of $571k IGMS by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| IGMS | SELL | 2024-03-15 | $40K | — | Filing → |
| IGMS | SELL | 2023-12-15 | $44K | — | Filing → |
| IGMS | SELL | 2023-11-29 | $5K | — | Filing → |